Neurological Manifestations of Primary Immunodeficiency Diseases

Picard C AL-Herz W Bousfiha A et al . Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency 2015. J Clin Immunol. 2015;35:696-726.

Boyle JM Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27:497-502.

Yee A De Ravin SS Elliott E Ziegler JB ; Contributors to the Australian Paediatric Surveillance Unit. Severe combined immunodeficiency: a national surveillance study. Pediatr Allergy Immunol. 2008;19:298-302.

Wood PM. Primary antibody deficiency syndromes. Curr Opin Hematol. 2010;17:356-361.

Smith CIE Conley ME. X-linked agammaglobulinemia and autosomal recessive agammaglobulinemia. In: Ochs HD Smith CIE Puck JM , eds. Primary Immunodeficiency Diseases. A Molecular and Genetic Approach. 3rd ed. New York, NY: Oxford University Press; 2014:299-323.

Shaghaghi M Parvaneh N Ostad-Rahimi P et al . Combined immunodeficiency presenting with vaccine-associated paralytic poliomyelitis: a case report and narrative review of literature. Immunol Invest. 2014;43:292-298.

Hermaszewski RA Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993;86:31-42.

Dehkordy SF Aghamohammadi A Ochs HD Rezaei N. Primary immunodeficiency diseases associated with neurologic manifestations. J Clin Immunol. 2012;32:1-24.

Schaer M Eliez S. From genes to brain: understanding brain development in neurogenetic disorders using neuroimaging techniques. Child Adolesc Psychiatr Clin N Am. 2007;16:557-579.

Driscoll DA Sullivan KE. DiGeorge syndrome: a chromosome 22q11.2 deletion syndrome. In: Ochs HD Smith CIE Puck JM , eds. Primary Immunodeficiency Diseases. A Molecular and Genetic Approach. 3rd ed. New York, NY: Oxford University Press; 2014:580-592.

Gothelf D Schaer M Eliez S. Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome. Dev Disabil Res Rev. 2008;14:59-68.

Sauer AV Aiuti A. New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapy. Curr Opin Allergy Clin Immunol. 2009;9:496-502.

Nofech-Mozes Y Blaser SI Kobayashi J Grunebaum E Roifman CM. Neurologic abnormalities in patients with adenosine deaminase deficiency. Pediatr Neurol. 2007;37:218-221.

Hönig M Albert MH Schulz A et al . Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications. Blood. 2007;109:3595-3602.

Camici M Micheli V Ipata PL Tozzi MG. Pediatric neurological syndromes and inborn errors of purine metabolism. Neurochem Int. 2010;56:367-378.

Hirschhorn R Grunebaum E Roifman C Candotti F. Immunodeficiency due to defects of purine metabolism. In: Ochs HD Smith CIE Puck JM , eds. Primary Immunodeficiency Diseases. A Molecular and Genetic Approach. 3rd ed. New York, NY: Oxford University Press; 2014:188-230.

Ozkinay F Pehlivan S Onay H et al . Purine nucleoside phosphorylase deficiency in a patient with spastic paraplegia and recurrent infections. J Child Neurol. 2007;22:741-743.

Tabarki B Yacoub M Tlili K Trabelsi A Dogui M Essoussi AS. Familial spastic paraplegia as the presenting manifestation in patients with purine nucleoside phosphorylase deficiency. J Child Neurol. 2003;18:140-141.

Tam DA Jr Leshner RT. Stroke in purine nucleoside phosphorylase deficiency. Pediatr Neurol. 1995;12:146-148.

Frappart PO Mckinnon PJ. Ataxia-telangiectasia and related diseases. Neuromolecular Med. 2006;8:495-511.

Perlman S Becker-Catania S Gatti RA. Ataxia-telangiectasia: diagnosis and treatment. Semin Pediatr Neurol. 2003;10:173-182.

Tavani F Zimmerman RA Berry GT Sullivan K Gatti R Bingham P. Ataxia-telangiectasia: the pattern of cerebellar atrophy on MRI. Neuroradiology. 2003;45:315-319.

Ball LG Xiao W. Molecular basis of ataxia telangiectasia and related diseases. Acta Pharmacol Sin. 2005;26:897-907.

Gazit Y Mory A Etzioni A et al . Leukocyte adhesion deficiency type II: long-term follow-up and review of the literature. J Clin Immunol. 2010;30:308-313.

Katyal S Mckinnon PJ. DNA repair deficiency and neurodegeneration. Cell Cycle. 2007;6:2360-2365.

Distel L Neubauer S Varon R Holter W Grabenbauer G. Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome. Med Pediatr Oncol. 2003;41:44-48.

Wegner RD German JJ Chrzanowska KH Digweed M Stumm M. Chromosomal instability syndromes other than ataxia-telangiectasia. In: Ochs HD Smith CIE Puck JM , eds. Primary Immunodeficiency Diseases. A Molecular and Genetic Approach. 3rd ed. New York, NY: Oxford University Press; 2014:632-661.

Bekiesińska-Figatowska M Chrzanowska KH Jurkiewicz E et al . Magnetic resonance imaging of brain abnormalities in patients with the Nijmegen breakage syndrome. Acta Neurobiol Exp (Wars). 2004;64:503-509.

Gao Y Sun Y Frank KM et al . A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell. 1998;95:891-902.

Enders A Fisch P Schwarz K et al . A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. J Immunol. 2006;176:5060-5068.

Blundred RM Stewart GS. DNA double-strand break repair, immunodeficiency and the RIDDLE syndrome. Expert Rev Clin Immunol. 2011;7:169-185.

Hagleitner MM Lankester A Maraschio P et al . Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet. 2008;45:93-99.

Finocchi A Claps A Serafinelli J et al . Chronic granulomatous disease presenting with salmonella brain abscesses. Pediatr Infect Dis J. 2014;33:525-528.

Etzioni A. Defects in the leukocyte adhesion cascade. Clin Rev Allergy Immunol. 2010;38:54-60.

Etzioni A Tonetti M. Leukocyte adhesion deficiency II-from A to almost Z. Immunol Rev. 2000;178:138-147.

Freeman AF Holland SM. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Pediatr Res. 2009;65(5 pt 2):32R-37R.

Freeman AF Collura-Burke CJ Patronas NJ et al . Brain abnormalities in patients with hyperimmunoglobulin E syndrome. Pediatrics. 2007;119:e1121-e1125.

Renner ED Puck JM Holland SM et al . Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. J Pediatr. 2004;144:93-99.

Yang L Fliegauf M Grimbacher B. Hyper-IgE syndromes: reviewing PGM3 deficiency. Curr Opin Pediatr. 2014;26:697-703.

Zhang Y Yu X Ichikawa M et al . Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol. 2014;133:1400-1409.

Carlsson G Van’t Hooft I Melin M et al . Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J Intern Med. 2008;264:388-400.

Faiyaz-UL-Haque M AL-Jefri A AL-Dayel F et al . A novel HAX1 gene mutation in severe congenital neutropenia (SCN) associated with neurological manifestations. Eur J Pediatr 2010;169:661-666.

Roques G Munzer M Barthez MA et al . Neurological findings and genetic alterations in patients with Kostmann syndrome and HAX1 mutations. Pediatr Blood Cancer. 2014;61:1041-1048.

Kerr EN Ellis L Dupuis A Rommens JM Durie PR. The behavioral phenotype of school-age children with Shwachman-Diamond syndrome indicates neurocognitive dysfunction with loss of Shwachman-Bodian-Diamond syndrome gene function. J Pediatr. 2010;156:433-438.

Toiviainen-Salo S Mäkitie O Mannerkoski M Hämäläinen J Valanne L Autti T. Shwachman-Diamond syndrome is associated with structural brain alterations on MRI. Am J Med Genet A. 2008;146A:1558-1564.

Nunoi H Yamazaki T Kanegasaki S. Neutrophil cytoskeletal disease. Int J Hematol. 2001;74:119-124.

Nunoi H Yamazaki T Tsuchiya H et al . A heterozygous mutation of beta-actin associated with neutrophil dysfunction and recurrent infection. Proc Natl Acad Sci U S A. 1999;96:8693-8698.

Kaplan J De Domenico I Ward DM. Chediak-Higashi syndrome. Curr Opin Hematol. 2008;15:22-29.

Jacobi C Koerner C Fruehauf S Rottenburger C Storch-Hagenlocher B Grau AJ. Presynaptic dopaminergic pathology in Chediak-Higashi syndrome with Parkinsonian syndrome. Neurology. 2005;64:1814-1815.

Tardieu M Lacroix C Neven B et al . Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome. Blood. 2005;106:40-42.

Hosseinverdi S Hashemi H Aghamohammadi A Ochs HD Rezaei N. Ocular involvement in primary immunodeficiency diseases. J Clin Immunol. 2014;34:23-38.

Dotta L Parolini S Prandini A et al . Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. Orphanet J Rare Dis. 2013;8:168.

Shotelersuk V Dell’Angelica EC Hartnell L Bonifacino JS Gahl WA. A new variant of Hermansky-Pudlak syndrome due to mutations in a gene responsible for vesicle formation. Am J Med. 2000;108:423-427.

Enders A Zieger B Schwarz K et al . Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II. Blood. 2006;108:81-87.

Badolato R Parolini S. Novel insights from adaptor protein 3 complex deficiency. J Allergy Clin Immunol. 2007;120:735-741.

Gupta S Weitzman S. Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Rev Clin Immunol. 2010;6:137-154.

Trottestam H Beutel K Meeths M et al . Treatment of the X-linked lymphoproliferative, Griscelli and Chédiak-Higashi syndromes by HLH directed therapy. Pediatr Blood Cancer. 2009;52:268-272.

Sanal O Ersoy F Tezcan I et al . Griscelli disease: genotype-phenotype correlation in an array of clinical heterogeneity. J Clin Immunol. 2002;22:237-243.

Talaat KR Rothman JA Cohen JI et al . Lymphocytic vasculitis involving the central nervous system occurs in patients with X-linked lymphoproliferative disease in the absence of Epstein-Barr virus infection. Pediatr Blood Cancer. 2009;53:1120-1123.

Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr. 2007;166:95-109.

Henter JI Nennesmo I. Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. J Pediatr. 1997;130:358-365.

Goo HW Weon YC. A spectrum of neuroradiological findings in children with haemophagocytic lymphohistiocytosis. Pediatr Radiol. 2007;37:1110-1117.

Yang S Zhang L Jia C Ma H Henter JI Shen K. Frequency and development of CNS involvement in Chinese children with hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2010;54:408-415.

Bart IY Weemaes CM Schuitema-Dijkstra AR Smeets D de Vries E. Immunodeficiency in a child with partial trisomy 6p. Acta Paediatr. 2011;100:e92-e94.

Pulliero A Fazzi E Cartiglia C et al . The Aicardi-Goutières syndrome. Molecular and clinical features of RNAse deficiency and microRNA overload. Mutat Res. 2011;717:99-108.

Crow YJ Hayward BE Parmar R et al . Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat Genet. 2006;38:917-920.

Ali M Highet LJ Lacombe D et al . A second locus for Aicardi-Goutieres syndrome at chromosome 13q14-21. J Med Genet. 2006;43:444-450.

Saraiva JM Dinis A Resende C et al . Schimke immuno-osseous dysplasia: case report and review of 25 patients. J Med Genet. 1999;36:786-789.

Boerkoel CF O’Neill S André JL et al . Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr. 2000;159:1-7.

Clewing JM Antalfy BC Lücke T et al . Schimke immuno-osseous dysplasia: a clinic pathological correlation. J Med Genet. 2007;44:122-130.

Sigurdardottir S Myers SM Woodworth JM Raymond GV. Mental retardation and seizure disorder in Schimke immunoosseous dysplasia. Am J Med Genet. 2000;90:294-298.

Vulliamy TJ Dokal I. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex. Biochimie. 2008;90:122-130.

Hreidarsson S Kristjansson K Johannesson G Johannsson JH. A syndrome of progressive pancytopenia with microcephaly, cerebellar hypoplasia and growth failure. Acta Paediatr Scand. 1988;77:773-775.

Mitchell JR Wood E Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 1999;402:551-555.

Akaboshi S Yoshimura M Hara T et al . A case of Høyeraal-Hreidarsson syndrome: delayed myelination and hypoplasia of corpus callosum are other important signs. Neuropediatrics. 2000;31:141-144.

Roifman CM Chitayat D. Combined immunodeficiency, facial dysmorphism, optic nerve atrophy, skeletal anomalies and developmental delay: a new syndrome. Clin Genet. 2009;76:449-457.

Kranz C Basinger AA Güçsavaş-Calikoğlu M et al . Expanding spectrum of congenital disorder of glycosylation Ig (CDG-Ig): sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformations, and early lethality. Am J Med Genet A. 2007;143A:1371-1378.

Feske S. CRAC channelopathies due to mutations in ORAI1 and STIM1. In: Ochs HD Smith CIE Puck JM , eds. Primary Immunodeficiency Diseases. A Molecular and Genetic Approach. 3rd ed. New York, NY: Oxford University Press; 2014:279-285.

Roscioli T Wong M. Hepatic veno-occlusive disease with immunodeficiency. In: Ochs HD Smith CIE Puck JM , eds. Primary Immunodeficiency Diseases. A Molecular and Genetic Approach. 3rd ed. New York, NY: Oxford University Press; 2014:501-508.

Cullup T Kho AL Dionisi-Vici C et al . Recessive mutations in EPG5 cause Vici syndrome, a multisystem disorder with defective autophagy. Nat Genet. 2013;45:83-87.

Finocchi A Angelino G Cantarutti N et al . Immunodeficiency in Vici syndrome: a heterogeneous phenotype. Am J Med Genet A. 2012;158A:434-439.

Woods AG Woods CW Snow TM. Congenital disorders of glycosylation. Adv Neonatal Care. 2012;12:90-95.

Wolfe LA Krasnewich D. Congenital disorders of glycosylation and intellectual disability. Dev Disabil Res Rev. 2013;17:211-225.

Freeze HH Eklund EA Ng BG Patterson MC. Neurology of inherited glycosylation disorders. Lancet Neurol. 2012;11:453-466.

Lübbehusen J Thiel C Rind N et al . Fatal outcome due to deficiency of subunit 6 of the conserved oligomeric Golgi complex leading to a new type of congenital disorders of glycosylation. Hum Mol Genet. 2010;19:3623-3633.

Gattorno M Federici S Pelagatti MA et al . Diagnosis and management of autoinflammatory diseases in childhood. J Clin Immunol. 2008;28(suppl 1):S73-S83.

Doria A Zen M Bettio S et al . Autoinflammation and autoimmunity: bridging the divide. Autoimmun Rev. 2012;12:22-30.

Kubota T Koike R. Cryopyrin-associated periodic syndromes: background and therapeutics. Mod Rheumatol. 2010;20:213-221.

Miyamae T. Cryopyrin-associated periodic syndromes: diagnosis and management. Paediatr Drugs. 2012;14:109-117.

Haas D Hoffmann GF. Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J Rare Dis. 2006;1:13.

Simon A Kremer HP Wevers RA et al . Mevalonate kinase deficiency: evidence for a phenotypic continuum. Neurology. 2004;62:994-997.

Prieur AM. A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheumatol. 2001;19:103-106.

De Sanctis S Nozzi M Del Torto M et al . Autoinflammatory syndromes: diagnosis and management. Ital J Pediatr. 2010;36:57.

Goldbach-Mansky R. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA. Curr Rheumatol Rep. 2011;13:123-131.

Becker ML Rose CD. Blau syndrome and related genetic disorders causing childhood arthritis. Curr Rheumatol Rep. 2005;7:427-433.

Wang X Kuivaniemi H Bonavita G et al . CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy. Arthritis Rheum. 2002;46:3041-3045.